SCHEMBL2223523

SCHEMBL2223523

O=C(O)c1ncc(CS(=O)(=O)Cc2ccc(F)cc2)c(CO)c1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TP53 P04637 3/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
P4HTM Q9NXG6 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
EGLN1 Q9GZT9 1/20 0.33
NPC1 O15118 1/20 0.33
MITF O75030 1/20 0.33
HSP90AA1 P07900 1/20 0.33
AGTR1 P30556 1/20 0.33
PAX8 Q06710 1/20 0.33
TLR9 Q9NR96 1/20 0.33
KCNQ3 O43525 1/20 0.32
KCNQ2 O43526 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1503256 0.87 USP2 (0.39) USP2LMNANPSR1TP53ALDH1A1
SCHEMBL15746728 0.83 BRS3 (0.38) ALDH1A1P4HTMKMT2AEGLN1PDXK
SCHEMBL29829548 0.83 BRS3 (0.38) ALDH1A1P4HTMKMT2AEGLN1PDXK
SCHEMBL15746657 0.80 KDM4E (0.41) P4HTMKMT2AKDM4E
SCHEMBL2221780 0.77 KDM4E (0.47) ALDH1A1P4HTMKMT2AHDAC1KDM4E
SCHEMBL4306646 0.77 HCAR2 (0.35) P4HTMKMT2A
SCHEMBL15746710 0.77 NR4A2 (0.45) ALDH1A1EGLN1NPC1MAPT
SCHEMBL1503105 0.76 P4HTM (0.46) USP2LMNAALDH1A1P4HTMKMT2A
SCHEMBL15746686 0.75 HSD17B10 (0.38) LMNAALDH1A1SMN1; SMN2KMT2AEGLN1
SCHEMBL4302963 0.73 NPC1 (0.46) ALDH1A1SMN1; SMN2KMT2AEGLN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8742123-B2 HIV integrase inhibitors from pyridoxine TAIMED BIOLOGICS, INC. (TW) 2014-06-03 US disclosed
US-20110178120-A1 HIV INTEGRASE INHIBITORS FROM PYRIDOXINE AMBRILIA BIOPHARMA, INC. (CA) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178120-A1 HIV INTEGRASE INHIBITORS FROM PYRIDOXINE PNPO, CCNB1, BLVRB USP2 4114/4885LMNA 719/4885NPSR1 3392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.